82 related articles for article (PubMed ID: 20842634)
21. Structures of Abeta-related peptide--monoclonal antibody complexes.
Gardberg A; Dice L; Pridgen K; Ko J; Patterson P; Ou S; Wetzel R; Dealwis C
Biochemistry; 2009 Jun; 48(23):5210-7. PubMed ID: 19385664
[TBL] [Abstract][Full Text] [Related]
22. Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease.
Pramanik D; Dey SG
J Am Chem Soc; 2011 Jan; 133(1):81-7. PubMed ID: 21141958
[TBL] [Abstract][Full Text] [Related]
23. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
24. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
25. Iron(II) binding to amyloid-β, the Alzheimer's peptide.
Bousejra-ElGarah F; Bijani C; Coppel Y; Faller P; Hureau C
Inorg Chem; 2011 Sep; 50(18):9024-30. PubMed ID: 21800824
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
Derrick JP; Maiden MC; Feavers IM
J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
[TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated immunotherapy for Alzheimer's disease.
Solomon B
Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
Arbel M; Solomon B
Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis for passive immunotherapy of Alzheimer's disease.
Gardberg AS; Dice LT; Ou S; Rich RL; Helmbrecht E; Ko J; Wetzel R; Myszka DG; Patterson PH; Dealwis C
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15659-64. PubMed ID: 17895381
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer β-amyloid peptide.
Di Scala C; Troadec JD; Lelièvre C; Garmy N; Fantini J; Chahinian H
J Neurochem; 2014 Jan; 128(1):186-95. PubMed ID: 23919567
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation.
Ștefănescu R; Lupu L; Manea M; Iacob RE; Przybylski M
J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29322650
[TBL] [Abstract][Full Text] [Related]
32. Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation.
Miles LA; Crespi GA; Doughty L; Parker MW
Sci Rep; 2013; 3():1302. PubMed ID: 23416764
[TBL] [Abstract][Full Text] [Related]
33. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
Ramakrishnan M; Kandimalla KK; Wengenack TM; Howell KG; Poduslo JF
Biochemistry; 2009 Nov; 48(43):10405-15. PubMed ID: 19775170
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies.
Crespi GA; Hermans SJ; Parker MW; Miles LA
Sci Rep; 2015 Apr; 5():9649. PubMed ID: 25880481
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies.
Zhao J; Nussinov R; Ma B
J Biol Chem; 2017 Nov; 292(44):18325-18343. PubMed ID: 28924036
[TBL] [Abstract][Full Text] [Related]
36. Development of a novel radioimmunoassay to detect autoantibodies to amyloid beta peptides in the presence of a cross-reactive therapeutic antibody.
Sloan JH; Ackermann BJ; O'Dell M; Bowsher RR; Dean RA; Konrad RJ
J Pharm Biomed Anal; 2011 Dec; 56(5):1029-34. PubMed ID: 21868184
[TBL] [Abstract][Full Text] [Related]
37. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
Cehlar O; Skrabana R; Revajova V; Novak M
Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
[TBL] [Abstract][Full Text] [Related]
38. Structure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution.
Mirza Z; Pillai VG; Zhong WZ
Int J Mol Sci; 2014 Mar; 15(3):4221-36. PubMed ID: 24619194
[TBL] [Abstract][Full Text] [Related]
39. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.
Arndt JW; Qian F; Smith BA; Quan C; Kilambi KP; Bush MW; Walz T; Pepinsky RB; Bussière T; Hamann S; Cameron TO; Weinreb PH
Sci Rep; 2018 Apr; 8(1):6412. PubMed ID: 29686315
[TBL] [Abstract][Full Text] [Related]
40. Hybridization of an Aβ-specific antibody fragment with aminopyrazole-based β-sheet ligands displays striking enhancement of target affinity.
Hellmert M; Müller-Schiffmann A; Peters MS; Korth C; Schrader T
Org Biomol Chem; 2015 Mar; 13(10):2974-9. PubMed ID: 25613910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
